You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 1, 2025

CLINICAL TRIALS PROFILE FOR PROBENECID; SULOPENEM ETZADROXIL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for probenecid; sulopenem etzadroxil

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03354598 ↗ Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women Completed Iterum Therapeutics, International Limited Phase 3 2018-08-01 This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability, and safety of oral sulopenem-etzadroxil/probenecid versus oral ciprofloxacin for treatment of uncomplicated urinary tract infection (uUTI) in adult women
NCT03354598 ↗ Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women Completed Iterum Therapeutics, US Limited Phase 3 2018-08-01 This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability, and safety of oral sulopenem-etzadroxil/probenecid versus oral ciprofloxacin for treatment of uncomplicated urinary tract infection (uUTI) in adult women
NCT03357614 ↗ Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults Completed Iterum Therapeutics, International Limited Phase 3 2018-09-18 This is a prospective, phase 3, randomized, multicenter, double-blind, double-dummy study to compare the efficacy and safety of sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin for the treatment of complicated urinary tract infections (cUTI) in adults.
NCT03357614 ↗ Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults Completed Iterum Therapeutics, US Limited Phase 3 2018-09-18 This is a prospective, phase 3, randomized, multicenter, double-blind, double-dummy study to compare the efficacy and safety of sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin for the treatment of complicated urinary tract infections (cUTI) in adults.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for probenecid; sulopenem etzadroxil

Condition Name

Condition Name for probenecid; sulopenem etzadroxil
Intervention Trials
Urinary Tract Infections 4
Antibiotic Resistant Infection 3
Complicated Infection 2
Complicated Urinary Tract Infections 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for probenecid; sulopenem etzadroxil
Intervention Trials
Communicable Diseases 5
Urinary Tract Infections 4
Infections 4
Infection 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for probenecid; sulopenem etzadroxil

Trials by Country

Trials by Country for probenecid; sulopenem etzadroxil
Location Trials
United States 49
Estonia 2
Latvia 2
Hungary 2
Georgia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for probenecid; sulopenem etzadroxil
Location Trials
California 4
Texas 3
Ohio 3
Montana 3
Idaho 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for probenecid; sulopenem etzadroxil

Clinical Trial Phase

Clinical Trial Phase for probenecid; sulopenem etzadroxil
Clinical Trial Phase Trials
Phase 3 4
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for probenecid; sulopenem etzadroxil
Clinical Trial Phase Trials
Completed 3
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for probenecid; sulopenem etzadroxil

Sponsor Name

Sponsor Name for probenecid; sulopenem etzadroxil
Sponsor Trials
Iterum Therapeutics, International Limited 5
Iterum Therapeutics, US Limited 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for probenecid; sulopenem etzadroxil
Sponsor Trials
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.